CAVAMAX W7 is a mid-size cyclodextrin that is commonly used in the pharmaceutical industry. With its ability to solubilize and stabilize intermediate size molecules, CAVAMAX W7 is useful for formulating various active pharmaceutical ingredients. It helps increase the bioavailability of poorly soluble drugs by facilitating their dissolution and absorption. CAVAMAX W7 also helps mask unpleasant odors and tastes, allowing for development of formulations with improved organoleptic properties. Its versatility and safety make CAVAMAX W7 a popular excipient for oral and topical drug delivery systems. CAVAMAX W7's unique molecular structure enables it to encapsulate guest molecules and modify drug release profiles. Pharmaceutical manufacturers leverage these functionalities of CAVAMAX W7 to develop innovative drug products with enhanced efficacy and patient compliance.